Lonza L7 hiPSC Reprogramming and hPSC Culture System

Friday, 27 June, 2014 | Supplied by: Capsugel Australia Pty Ltd


Lonza introduces its L7 hiPSC Reprogramming and hPSC Culture System for basic stem-cell research, disease modelling, drug development and regenerative medicine. The offering includes tools to simplify and streamline the stem-cell culturing and reprogramming workflow. The culture system supports the generation of reproducible, clinically relevant data as a solid basis for more efficient drug development and accelerated progress in regenerative medicine.

The stem-cell reprogramming and culture system includes seven key components that are aligned and function as a robust workflow: primary cells, including disease phentoypes; Nucleofector technology; hPSC reprogramming kits; hPSC medium; hPSC matrix; hPC passaging solution; hPSC cryosolution.

The culture system is claimed to be the only complete solution for the generation of induced pluripotent stem-cells (iPSCs), the maintenance of human embryonic stem-cells (hESCs) and iPSCs under defined, xeno-free conditions. It allows for every other day feeding and supports long-term culture and maintenance of hPSCs. The system thus provides a seamless transition from the lab bench to clinical development applications.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

ALA Scientific Instruments RuFus cell unroofing system for plasma membrane isolation

ALA Scientific Instruments offers RuFus, a complete and user-friendly system for performing cell...

Lonza plateable mouse hepatocytes

Lonza provides plateable mouse hepatocytes from the four most common research mouse strains,...

PEPperPRINT cLIFT peptide microarray platform

At the core of the technology is a laser-based transfer process that is designed to deposit amino...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd